Sell4

Paysign, Inc.

PAYS

Total Value

$403.2K

Net $62.6K sold

Filing Date

Sep 4, 2026

2 transactions

Sales

$62.6K

1 transaction

Trade Summary

On Nov 13, 2025 through May 22, 2026, Turner Matthew Baker, PRES., PATIENT AFFORDABILITY, sold $403.2K of Paysign, Inc. (PAYS) across 2 transactions. The filing covers Common Stock and reflects net selling of $62.6K. Reported prices ranged from $4.16 to $6.72. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Price at the Time of the Trade

PAYS daily price with the insider's sale marked at $4.16.

Sold near the 13-month low · the stock trades 213% higher today.

Price data is delayed and provided for context only — not investment advice.

Insider Information

Name: Turner Matthew Baker
Role: PRES., PATIENT AFFORDABILITY
Location: HENDERSON, NV

Filing Details

Filing Date: Sep 4, 2026
Transaction Date: Nov 13, 2025
Accession Number: 0001683168-26-006985
Form Type: 4
Net Trading Amount: -$62.6K

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Nov 13, 2025	Common Stock	233,333	—	Grant/Award	—
Feb 3, 2026	Common Stock	15,057	$4.16	Sale	$62.6K
May 22, 2026	Common Stock	50,681	$6.72	Tax Withholding	$340.6K

Want live alerts when Turner Matthew Baker trades again?

Download Insider Trades to track PAYS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date.
(F2)Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.
(F3)Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turner Matthew Baker

(Last)

(First)

(Middle)

2615 ST ROSE PARKWAY

(Street)

HENDERSON

89052

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Paysign, Inc. [ PAYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	PRES., PATIENT AFFORDABILITY

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/13/2025		A		233,333⁽¹⁾	A	$0.00	470,000	D
Common Stock	02/03/2026		S⁽²⁾		15,057	D	$4.16	454,943	D
Common Stock	05/22/2026		F⁽³⁾		50,681	D	$6.72	404,262	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date.

2. Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.

3. Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.

	/s/ Matthew Baker Turner	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001683168-26-006985.

Paysign, Inc.

Trade Summary

Price at the Time of the Trade

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when Turner Matthew Baker trades again?

Footnotes

SEC Form 4

SEC Filing

Price at the Time of the Trade

SEC Form 4